Compare Cemex S.A.B. de C.V. Sponsored ADR (CX) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cemex S.A.B. de C.V. Sponsored ADR vs Eli Lilly And Co — how do they compare? Cemex S.A.B. de C.V. Sponsored ADR trades at $9.49 (market cap $13.79B), while Eli Lilly And Co trades at $1,175 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 75.4× Cemex S.A.B. de C.V. Sponsored ADR's market cap, and Cemex S.A.B. de C.V. Sponsored ADR pays the higher dividend (1.3%). Which is the better fit depends on your goals — on Pluang, investors hold Cemex S.A.B. de C.V. Sponsored ADR for 1 Days and Eli Lilly And Co for 93 Days on average.
| CX | LLY | |
|---|---|---|
Market Cap | $13.79B | $1.04T |
Volume | 3,993,982 | 3,064,878 |
Sector | Basic Materials | Health |
52-Week High | $13.55 | $1.28K |
52-Week Low | $9.12 | $799.57 |
Typical Hold Time | 1 Days | 93 Days |
Enterprise Value | $19.79B | $1.09T |
Dividend Yield | 1.3% | 0.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,176.69, down 1.01% on the day, amid a bullish technical outlook and strong fundamental performance. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 consensus. Revenue surged to $65.18B in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing growth prospects.
The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include elevated valuation multiples and competitive pressures in the pharmaceutical sector. With a consensus price target of $1,350, upside potential exists, but investors should weigh execution risks against the company's innovation pipeline.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cemex S.A.B. de C.V. Sponsored ADR
Cemex produces, distributes, markets, and sells cement, ready-mix concrete, aggregates, and other construction materials. Its operations serve markets around the world.
Read more on CX →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
